McN 5707
Chemical compound
McN-5707 is a chemical compound that was developed as a potential antipsychotic medication. It is notable for its unique pharmacological profile and its role in the study of dopamine receptor antagonism.
Chemical Structure
McN-5707 is a member of the butyrophenone class of compounds, which are characterized by their phenylbutylpiperidine structure. The chemical structure of McN-5707 includes a piperidine ring, which is a common feature in many antipsychotic drugs. This structure is crucial for its interaction with dopamine receptors in the brain.
Pharmacology
McN-5707 acts primarily as a dopamine receptor antagonist, which means it blocks the action of dopamine, a neurotransmitter that is involved in many brain functions, including mood, motivation, and reward. By antagonizing dopamine receptors, McN-5707 can potentially reduce symptoms of schizophrenia and other psychotic disorders.
Dopamine Receptor Antagonism
The primary mechanism of action for McN-5707 is its ability to bind to and block D2 receptors. This action is similar to that of other antipsychotic drugs, such as haloperidol and chlorpromazine. By inhibiting dopamine activity, McN-5707 can help alleviate symptoms such as hallucinations and delusions.
Development and Research
McN-5707 was developed during a period of extensive research into antipsychotic medications. Although it showed promise in preclinical studies, it did not advance to widespread clinical use. However, the research conducted on McN-5707 contributed to a better understanding of the role of dopamine in psychotic disorders and the development of new therapeutic agents.
Potential Applications
While McN-5707 itself is not used clinically, its study has provided insights into the design of new antipsychotic drugs. Researchers continue to explore compounds with similar structures and mechanisms of action to develop more effective treatments with fewer side effects.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD